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Abstract
OBJECTIVE: To study the anticancer mechanism of
polyphyllin I (PPI), a Traditional Chinese Medicine,
on the ovarian cancer cell line HO-8910PM in vitro.
METHODS: Transwell chamber invasive assays
were used to investigate the inhibitory capacity of
PPI on HO-8910PM metastasis. Gene expression
profiling chips was used to screen differentially ex-
pressed genes between experiment group and con-
trol group. Reverse transcription PCR and Western
blotting were used to determine mRNA and pro-
tein levels.
RESULTS: With increasing PPI concentration, the
metastatic capacity of cells decreased, with signifi-
cance differences between the experimental and
control groups (P<0.01) as well as between two
concentration groups. Gene expression profiling
identified 123 differentially expressed genes, of
which 70 were downregulated and 53 were upregu-
lated. The genes were involved in multiple signal
transduction pathways, including apoptosis, prolif-
eration and metastasis. Real-time PCR (RT-PCR)
showed that differential genes PIK3C2B, Caspase 9
and Wnt5A were downregulated with increasing
PPI, showing an evident dose-effect relationship.
The c-Jun was an exception. As the PPI dosage in-
creased and the exposure time was extended,
c-Jun relative expression showed an upward trend.
There were significant differences between the ex-
periment and control (P<0.05). Western blot analy-
ses showed that PPI treatment decreased levels of
Caspase 9, Wnt5A and PIK3C2B and increased acti-
vatedCaspase9,c-Junandp-c-Junexpression levels.
CONCLUSION: PPI has strong antitumor and anti
transfer activity. It can activate c-Jun expression
and the JNK signaling pathway, elicit cell apoptosis
via the mitochondrial-mediated Caspase activation
pathway, and finally inhibit tumor growth and mi-
gration in vitro. The downregulation of PIK3C2B
and Wnt5A jointly inhibit the proliferation and me-
tastasis of HO-8910PM. PPI may be a novel treat-
ment for ovarian cancer.
© 2013 JTCM. All rights reserved.
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INTRODUCTION
Ovarian cancer is a common malignant neoplasm of fe-
male reproductive organs. Although the incidence of
ovarian cancer ranks third after cervical cancer and
uterine cancer, its mortality is the highest of all gyneco-
logical tumors. Ovarian cancer has no apparent early
symptoms, so when the cancer is discovered, it is al-
ready late stage. Although some ovarian cancer patients
have a good postoperative reaction, many die from re-
currence and metastasis. The 5-year survival rate of
ovarian cancer is only 25%-30%.1
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Traditional Chinese Medicine (TCM) is important in
treating ovarian cancer with satisfactory clinical effica-
cy. TCM treatment can inhibit tumor cell growth and
improve the patient's outcome with few adverse effects.
Thus, TCM is appropriate for long-term use.2
Chonglou (Rhizoma Paridis Chonglou), which is the
root of Paris polyphylla, in the lily family. Modern
pharmacological research suggests that Chonglou (Rhi-
zoma Paridis Chonglou) has a wide range of medicinal
activities, including anti-cancer, immunoregulatory
and cardiovascular effects. Chonglou (Rhizoma Paridis
Chonglou) is extensively applied in the treatment of ma-
lignant lymphomas, lung cancer, nasopharyngeal carci-
noma, brain tumors and digestive system carcinomas.
Polyphyllin and extracts from Chonglou (Rhizoma Pari-
dis Chonglou) show good antitumor effects in vitro,
through a variety of targets and pathways. Their mecha-
nism might be linked to the cytotoxicity of Chonglou
(Rhizoma Paridis Chonglou), which causes promotion
of apoptosis, affects the growth cycle of tumor cells, in-
hibits tumor angiogenesis and regulates the immune
function of patients.3-5
An earlier study from our research team found that
monomer polyphyllin I (PPI) inhibits the in vitro
growth and promotes apoptosis of the highly metasta-
sic ovarian cancer cell line HO-8910PM.6 However,
the molecular mechanism is not clear. Reports on the
effects of PPI on the metastasis of ovarian cancer cells
are rare. For this reason, this paper investigated the in-
hibitory capacity of PPI on HO-8910PM metastasis us-
ing transwell assays, and the targets and possible signal
pathways through which PPI acts were studied. We
used gene expression profiling chips to screen differen-
tially expressed genes. Real-time PCR (RT-PCR) and
Western blots were used to investigate possible targets
and signal transduction pathways of PPI. Thus, the
mechanism of PPI for inhibiting growth, inducing
apoptosis and reducing metastasis of HO-8910PM
cells was investigated. Our findings provide valuable in-




The highly metastatic ovary serous adenocarcinoma
cell line HO-8910PM was generated and provided by
Zhejiang Cancer Research Institute, Zhejiang Cancer
Hospital.7
PPI
Monomer PPI powder (National Institute for the Con-
trol of Pharmaceutical and Biological Products, Beijing,
China, batch number 111590-200402) has a molecu-
lar weight of 855.03 daltons. Dimethyl sulfoxide
(DMSO) was used to dissolve PPI powder in a concen-
trated solution (100 μg/μL), which was stored at －
20℃ . A working solution was prepared using RP-
MI1640 medium according to experimental needs,
with the final concentration of DMSO less than 0.5%.
Main reagents
RPMI1640 medium (HyClon, Logan, UT, USA), fetal
bovine serum (FBS) (HyClon, Logan, UT, USA), gene
expression profiling (Illumina, Santiago, CA, USA),
RNA amplification kit (Illumina, Santiago CA, USA ),
human genome-wide gene expression profile hybrid kit
(Illumina, Santiago CA, USA), total RNA extraction
kit (Qiagen, Germany), reverse transcription kit Prime-
Script RT reagent kit (TaKaRa, Japan), Matrigel matrix
basement membrane (BD Biosciences, Franklin, NJ,
USA), bovine serum albumin (BSA, Watson BioMedi-
cals Inc, Shanghai, China), primers (Takara, Dalian,
China); PCR reagent kit, SYBR Premix Ex Taq TMII
(Takara, Dalian, China); antibodies for β-actin, Cas-
pase 9, cleaved Caspase 9, PIK3C2B, c-Jun,
ps63-c-Jun, Wnt5A, and secondary antibody were
from Abcam (Cambridge, UK) and CST (Boston,
MA, USA), and the ECL reagent kit was from Thermo
(Rockford, IL, USA ).
Transwell chamber invasive assay
The working glue was Matrigel solution with diluted
Matrigel (RPMI1640 without serum, 1∶3), with 30 μL
added to each chamber,. HO-8910PM cells were taken
in logarithm phrase and PPI at doses of 0, 0.75 or 1.5 μg/
mL was added. After 24 h, supernatant (including sus-
pended cells) was collected and adherent cells were
picked for transwell chambers. Serumless RPMI1640
medium containing 0.1% BSA was used to resuspend
cells at 3 × 104 cells/chamber, with 300 μL added to
the upper layer and 600 μL of 1640 medium contain-
ing 10% FBS added to the bottom layer. Replicates
were performed for each group. Cells were placed at
37℃ , 5% CO2 incubator with saturated humidity for
48 h. Chambers were removed after 48 h and Matrigel
carefully removed with cotton swabs. Chambers were
washed with phosphate buffer saline (PBS) once and
cells were stained in 2% crystal violet for 5 min. Cham-
bers were removed, washed with PBS and dried. Invad-
ing cells were counted in five randomly selected fields
of vision for each chamber under a microscope.
Screening by gene expression profiling
Adherent HO-8910PM cells were grown to logarith-
mic phase and cells were either treated with 1.5 μg/mL
PPI (experimental group) or untreated (control group).
After 24 h, collected the cells and extracted total RNA.
In an ice bath, reverse transcription synthesized
first-strand and second-strand cDNA, which was puri-
fied. Hybridization was according to the instructions
of the BeadChip assay (Genergy Biotech, Shanghai,
China).
Illumina iscan was used to scan chips at the appropri-
ate scanning speed, and the signal intensity of each mi-
crosphere was automatically analyzed by the software
(Illumina, Santiago, CA, USA). P value and Diffscore
326
JTCM |www. journaltcm. com June 15, 2013 |Volume 33 | Issue 3 |
Gu LH et al. / Experimental Study
were obtained. Diffscore, which offers directionality,
was transformed from the P value. P values were gener-
ated for the differences of average signals of the experi-
ment and control groups using the formula Diffscore=
10×sgn (μref-μcond) × log10 (p). When P was 0.05,
the Diffscore was±13; when P was 0.01, the Diffscore
was±20; when P was 0.001, the Diffscore was ±30. Ef-
fective genes (P<0.05) in either the experimental and
control group that had a Diffscore in the experimental
group that was less than -13 or more than 13 were de-
fined as differentially expressed genes. Function classifi-
cation and pathways of differentially expressed genes
were determined by submitting differential genes to
the DAVID Bioinformatics, repeating twice for parallel
experiments.
RT-PCR verification of differential genes
HO-8910PM cells at 50%-60% confluence were treat-
ed with different concentrations of PPI for 6, 12 and
24 h. Total RNA was extracted from cells. Reverse tran-
scription of RNA to cDNA was according to the kit
manual.
PCR amplification conditions were at 95℃ for 10 min,
95℃ 15 s, and 60℃ 1 min (40 cycles). Dissolution
curves were used to test if PCR amplified products
produced nonspecific bands using amplification con-
ditions of 95℃ 15 s, 60℃-95℃, increased by 1℃ ev-
ery min, 95℃ 15 s. Ct value was automatically ana-
lyzed by SDS software(ABI7500, Carlsbad, CA,
USA).
Statistical processing used SPSS 18.0 software. Data
from the two groups were compared by t-test, with P<
0.05 indicating statistical significance. Relative expres-
sion of genes was calculated using the 2-△△ Ct method.
Specific primer sequences (Table 1).
Verification of differentially expressed proteins
HO-8910PM cells in logarithmic phase were seeded in
a culture vessel. After 24 h, cells were treated by PPI at
a final concentration of 0.75 or 1.5 μg/mL. The con-
trol was only added the same volume medium. Pro-
teins of cells were extracted after treatment for 24 h.
Protein samples (50 μg) were separated on 10% sodi-
um dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) at 100 V for 90 min. Proteins were
wet-transferred at 4℃ for 100 V, 90 min to PVDF
membranes. Membrane were treated with 5% BSA for
3 h and incubated overnight at 4℃ with antibodies:β-actin 1∶2000, caspase 9 1∶300, cleaved Caspase 9 1∶
300, PIK3C2B 1∶500, c-Jun 1∶500, or Wnt5a 1∶
1000. After washing with Tris-HCL Buffer Solution
Tween (TBST), membranes were treated with second-
ary antibody (goat anti-mouse IgG 1∶2000 or goat an-
ti-rabbit IgG 1∶5000) for 2 h at room temperature be-
fore washing with TBST. ECL was used for color devel-
opment and a gel imager (Bio-Rad, Universal Hood II,
Hercules, CA, USA) was used for imaging. Procedures
of SDS-PAGE electrophoresis were repeated three
times.
RESULTS
Inhibitory effects of PPI on HO-8910PM cell
metastasis
The inhibitory effects of different concentrations of
PPI on HO-8910PM cell in vitro metastasis varied.
With PPI concentration increased, the metastatic ca-
pacity of the cells decreased. Differences were signifi-
cant between the experimental and control groups (P<
0.01) and between the two concentration groups (P<
0.01) (Table 2 and Figure1).
Screening of differentially expressed genes
Illumina chip results found 123 genes that tended to
vary in the two repeated experiments (Diffscore <-13
or >13). Of these, 70 genes were downregulated and
53 genes were upregulated. Among the 123 differential-
ly expressed genes, 71 that showed significant differenc-
es (Diffscore <-30 or >30, P=0.001) were linked to cell
apoptosis, proliferation, metastasis, invasion, or angio-
genesis (Table 3).
Differential genes and proteins expression
According to the results of the chip screening, we con-
ducted RT-PCR on several selected genes related to cell
apoptosis and metastasis with significant differences in
treated and untreated cells. PIK3C2B, Caspase 9 and
Wnt5A genes were downregulated with increasing PPI,
showing an evident dose-effect relationship. Expression
also showed a downward trend with extended PPI ex-
posure, suggesting decreased PPI effects with time. The
































Table 2 Effect of Polyphyllin I on migration capacity of
HO-8910PM cells after 48 h ( xˉ ±s)
Notes: Compared with control group, aP<0.01; compared with
0.75 μg/mL group, bP<0.01.
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creased and the exposure time was extended, c-Jun rela-
tive expression showed an upward trend. There were
significant differences between the experiment and con-
trol (P<0.05) (Figure 2).
To further validate the mechanism by which PPI exerts
its effects, we analyzed the in vitro expression of the
crucial proteins. Western blot analyses showed that the
expression of Caspase 9, Wnt5A and PIK3C2B was
downregulated with increasing PPI concentration after
24 h, and activated Caspase 9 increased in expression
as the effect of the PPI concentration strengthened.
Otherwise,the expression of c -Jun and p-c-Jun were























































6 h 12 h 24 h
Time of treatment
c-Jun
Figure 2 RT-PCR analyses for HO-8910PM cells treated with different concentrations of PPI for 6, 12, 24 h respectively
PPI: polyphyllin I. PIK3C2B, CASPAS9 andWNT genes were downregulated with increasing PPI, showing an evident dose-effect re-
lationship. Expression also showed a downward trend with extended PPI exposure. The c-Jun gene was an exception. As the PPI
dosage increased and the exposure time was extended, c-Jun relative expression showed an upward trend.
A B C
Figure 1 Transwell chamber membrane invasion.
HO-8910PM cells were treated with different concentrations of PPI (crystal violet ×200). A: many cells were throught basement
membrane in control; B: with increasing PP I concentration (0.75μg/mL), the metastatic capacity of the cells decreased; C: few
cells could penetrate the basement membrane in 1.5μg/mL group. PPI: polyphyllin I. Differences were significant between the ex-









Control 0.75 μg/mL 1.5 μg/mL
Figure 3Western blot analyses on expression of caspase 9,Wnt and PIK3C2B
PPI: polyphyllin I. The expression of caspase 9, Wnt and PIK3C2B was downregulated with increasing PPI concentration after 24 h,
and activated caspase 9 increased in expression as the effect of the PPI concentration strengthened. C-Jun protein increased in
expression with increasing PPI dosage.
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Table 3 Differential gene expression in HO-8910PM cells treated with PPI among experimental and control groups
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DISCUSSION
Previous research from our group found that PPI killed
and inhibited the growth of ovarian cancer cells in vi-
tro.6 Ovarian serous cystadenocarcinoma is the malig-
nant neoplasm with the highest incidence and suscepti-
bility to abdominopelvic cavity metastasis and lymph
node metastasis of all ovarian cancers. In this study, we
simulated the in vivo environment to observe the effect
of PPI on the invasive ability of HO-8910PM cells in
an invasive basement membrane experiment (transwell
chamber assay). The results showed that the invasive
ability of the cells decreased with 0.75 or 1.5 μg/mL of
PPI for 48 h, with significant differences between treat-
ment and control groups. Thus, PPI had an inhibitory,
apoptosis and antimetastasis effect on HO-8910PM
cells in vitro.
The mechanisms of TCM on tumor growth and metas-
tasis mainly include inducing tumor cell apoptosis, reg-
ulating matrix metalloproteinase secretion, reversing
multidrug resistance, and enhancing antitumor immu-
nity.8-10 In order to study the mechanism of PPI, accord-
ing to the results of in vitro inhibition of proliferation
and metastasis on HO-8910PM, the study firstly
screen by Illmina gene expression profile. The results
show that there are 123 different genes, with 70 genes
downregulated and 53 genes upregulated. The genes
were involved in multiple signal transduction path-
ways, including apoptosis, proliferation and metastasis.
We propose that the anti-ovarian cancer effect of PPI
might be associated with genetic changes in these path-
ways.
Chip screening showed that the c-Jun gene of experi-
ments was upregulated compared to the control group.













































































































































































Table 3 Differential gene expression in HO-8910PM cells treated with PPI among experimental and control groups
331
JTCM |www. journaltcm. com June 15, 2013 |Volume 33 | Issue 3 |
Gu LH et al. / Experimental Study
which is activated in cell apoptosis after specific bind-
ing. JNK/c-Jun signaling pathway plays a critical role
in regulating a wide range of cellular activities from cell
proliferation and differentiation to programmed cell
death, and also in the diseases development, such as
cancer. Transcriptional factor c-Jun, one major mem-
ber of AP-1 family, is an important downstream effec-
tor of JNK activation. The increased phosphorylated
protein p-c-Jun indicating JNK/c-Jun signaling path-
ways are activated. The activation of the pathway leads
to the release of cytochrome C in mitochondria. Even-
tually it occur apoptosis. Caspases are a group of pro-
teinases with high homology that have a key role in
apoptosis. They are the important initiator in mito-
chondrial apoptosis pathway. Shi et al 11 studied saxifra-
gifolin D (SD) effects on growth inhibition and apop-
tosis induction of human liver cancer HepG2/ADM
cells. They found that after HepG2/ADM cells were
treated with SD, the protein level of procaspase 9 and
procaspase 3 increased and activated Caspase 9 and
Caspase 3 increased compared with the control. Dai et
al 12 reported that platycodin D from Jiegeng (Radix
Platycodi) had an inhibitory effect on the in vitro
growth of the human lung adenocarcinoma cell line
A549 and accelerated apoptosis via mitochondrial path-
way. The expression of activated Caspase 9 protein af-
ter 24 h increased with platycodin D concentration.
Xiao et al 13 found several apoptosis-related proteins
such as Caspase 9 and Caspase 3, were activated after
treatment with PPI for 24 h, and thereby accelerated
SKOV3 cell apoptosis. Through gene chip screening,
the experiments found that Caspase 9 showed de-
creased levels. RT-PCR indicated that Caspase 9 was
downregulated with time and PPI dose, with evident
dependence on time and dose. Protein levels in our
study indicated that Caspase 9 expression decreased
with PPI dose, and activated Caspase 9 (cleaved Cas-
pase 9) increased with PPI dose. This showed that PPI
activated Caspase 9, thus causeing apoptosis.
Furthermore, Liu et al 14 found that in colorectal can-
cer tissue VEGF-C expression was related to c-Jun ex-
pression in moderately and highly differentiated adeno-
carcinomas. With cancer progression, c-Jun protein ex-
pression gradually decreased while VEGF-C expression
gradually increased, suggesting that c-Jun protein
might be an inhibiting factor for VEGF-C expression.
Li et al 15 found that activated JNK induced cell au-
tophagy through upregulation of beclin1 expression.
RT-PCR and protein studies in our study showed that
c-Jun gene and protein levels were upregulated with in-
creasing PPI dosage. We hypothesize that PPI might ac-
tivate c-Jun expression and the JNK signaling pathway,
then induce apoptosis of HO-8910PM cells, mean-
while restrain angiogenesis gene expression including
VEGF, and therefore inhibit tumor cell metastasis.
PIK3C2B is a member of the PI3K family, which is im-
portant in proliferation, tumor conversion, cell surviv-
al, migration and cellular protein transport.16 Scrima et
al 17 found that high expression of PI3K promoted the
incidence and development of non-small cell lung can-
cer. By silencing subtype P110α of PI3K in
NCI-H460 cells, they discovered that PI3K inhibited
the expression of P110α and significantly inhibited
NCI-H460 cell growth. Du et al 18 showed that
HIF-1α binds to tumor inhibitor protein under nor-
mal oxygen concentrations. However, anaerobic condi-
tions inhibit the hydroxylation of HIF-1α and acceler-
ate its intranuclear transfer to generate an active com-
pound by binding to HIF-1β. In this way, HIF-1α ac-
celerates the transcription of VEGF and other angio-
genesis factors and increases tumor angiogenesis. Gene
and protein analysis in this paper indicated that
PIK3C2B expression in decreased in ovarian cancer
cells after PPI treatment with increasing PPI concentra-
tion. We propose that PPI might inhibit the expression
of genes that promote angiogenesis and decrease tumor
angiogenesis by downregulating the PIK3C2B gene,
which results in the inhibition of HO-8910PM cell
metastasis.
The Wnt family is important in cell proliferation, dif-
ferentiation and tumor formation. Wnt5A is a major
member of the Wnt family. Capable of activating the
Wnt5a/β-catenin pathway and the Wnt/Ca2 + pathway,
Wnt5A affects cell migration, invasion, and angiogene-
sis in tissues and is important for tissue recovery and
homeostasis. Thus Wnt5A expression may be upregu-
lated, downregulated or deleted in many tumors aris-
ing from the epithelium and mesoderm. The upregula-
tion of Wnt5A has been found in melanoma, lung,
breast, ovarian, gastric and prostate carcinoma.19-21
Compared with corresponding normal tissues, Wnt5A
expression in endometrial carcinoma and high-risk neu-
roblastoma is downregulated.22 Therefore, overexpres-
sion of Wnt5A has a distinctive cancer-inhibiting or
cancer-inducing effect, according to cell type. In this
study, compared with the control group, Wnt5A ex-
pression in the experimental group was decreased, pos-
sibly because of Wnt5A antagonism by PPI, which in-
hibits the proliferation and metastasis of HO-8910PM
cells.
In conclusion, this study demonstrated that PPI as a
TCM had a powerful antitumor and anti transfer activ-
ity. It could activate c-Jun expression and the JNK sig-
naling pathway, elicit cell apoptosis via the mitochon-
drial-mediated caspase activation pathway and finally
inhibit tumor growth and migration in vitro. Selective
intervention of apoptotic signals, induction of pro-
grammed cell apoptosis and inhibition of cancer cell
metastasis are effective means for treating malignant tu-
mors. So PPI might be used as a novel treatment for
ovarian cancer due to its multipathway effect on the
ovary serous adenocarcinoma cell line HO-8910PM.
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